Quantus

Beauty Skin

A406820 · KOSDAQ
₩1,676+2.20%
2026-08-03 close

Beauty Skin — what's the grade? And what signals are flashing today?

Open the exact grade & valuation bands with Pro →
Loading chart…
Close
AI Insight

Why these signals fired — only backtest-proven edge, told honestly

Why this signalSignal guide

Moving-average alignment
No

No active signal.

Explore this stock further
Review signal, financial and filing context in chat
Explore in chat →

Strong-buy signal — the real recordrecord · not a prediction

Not this one stock, but every strong-buy pick we actually published (Korea market). When this stock flashes the signal, it is treated by the same rule.(as of 2026-08-03)

Last 30 sessions
648 picks
Next-day win rate
49.2%
Avg next-day
-0.17%
vs market
+0.72%p

Beat the market on 62.1% of picks (each pick vs its own day’s market average).

Recent publish days (next-day win rate)
07-31 0%07-30 66.7%07-29 0%07-28 45%07-27 20%07-25 36.4%07-21 55.6%07-20 53.8%07-16 53.3%07-15 50%07-14 71.4%07-13 31.2%
This stock has not flashed this signal recently — the record above is the signal’s own, not this stock’s.

Entry is the latest close at publish time; next-day is the following close. “Market” is the equal-weighted average of every stock in the same market that day; delisted names are excluded from both. Fees, taxes and slippage are not included. An observed record over a short window, not a pre-registered backtest. Not investment advice.

Valuation Grades

Relative to 110 화학 peers · not investment advice

Pro unlocks the composite grade, 5 factors and sector rank · ₩19,900/mo

Financial safety

Reference indicatorAs of 2024
Distress zoneFinancial-metric reference signal
Altman Z'' zoneZ'' 0.58
Distress
Grey
Safe
The marker shows the current Z'' value within the displayed zones.
Altman Z''
0.58
Beneish M-Score
-3.61

No statistical flag

Sloan accrual
-16.81%

부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.

Factual information, not investment advice.

Earnings quality · Piotroski F-Score

5/9Moderate

Piotroski measures year-over-year financial improvement, not absolute quality.

Financial improvement score5/9

Profitability

  • Positive ROANot passed
  • Positive OCFPass
  • Improving ΔROAPass
  • Accruals (OCF > net income)Pass

Leverage & liquidity

  • Lower debtNot passed
  • Higher current ratioPass
  • No new sharesNot passed

Efficiency

  • Higher gross marginPass
  • Higher asset turnoverNot passed

Calculation note: F7(신주)은 equity/asset 유지로 근사

Already-stable companies may score lower when year-over-year improvement is limited.

Factual information, not investment advice.

Forensic signals

Anomaly and structural signals observed in the financial statements.

Margin trendWarning

영업외손익 급변 (영업이익 대비 40% 규모 변동) — 일회성 손익 주의. 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Factual information, not investment advice.

Industry structure

KRAs of 2026-08-03

화학

This stock is in 화학: revenue rank 77 of 109, share 0.1%.

77 / 1090.1%revenue share

Who dominates this industry?

  1. 1LG화학31.9%
  2. 2롯데케미칼13.3%
  3. 3금호석유화학4.7%
  4. 4DL3.7%
  5. 5코오롱인더3.2%
  6. 6뷰티스킨0.1%

Concentration

DistributedCR3 49.9%
HHI 1,298109 revenue members

HHI and CR3 are separate industrial-organization facts; they are not the polarization verdict.

Polarization

MixedConsistent

Polarization measures industry gaps and structure, not valuation, forecast, or investment advice.

Margin lens

IQR%p
8.66
Direction
확대
Level
보통
Years
6

Value lens

P90/P10
9.3
Median P/B
0.71
Level
넓음
n
98

Survivorship note: 현재 산업 멤버십을 과거 연도에 소급 적용 — 과거 진입·퇴출 기업 미반영(복원 불가)

Factual information, not investment advice.

Risk sensitivity — adverse assumptions

Metric changes under stated assumptions; not a forecast or investment advice.

Base metrics

Operating margin
-4.3%
Interest coverage
-2.1x
Return on equity (ROE)
-14.8%

Operating margin −5pp

Operating loss
Interest coverageBase -2.1x adverse case -4.5x
Return on equity (ROE)Base -14.8% adverse case -26.8%

Revenue −15%

Interest coverage risk
Interest coverageBase -2.1x adverse case -1.8x
Return on equity (ROE)Base -14.8% adverse case -13.4%

Interest rate +2pp

Interest coverage risk
Interest coverageBase -2.1x adverse case -1.3x
Return on equity (ROE)Base -14.8% adverse case -17.8%

Interest coverage limit

Already below the limit by 6.3pp

Interest coverage limit at an operating margin of 2%

Interest expense coverage threshold

Key suppliers · Annual report

Annual reportDART · 2026-03-19

Suppliers disclosed by the company in its 2026-03-19 annual report.

Suppliers without disclosed amount

OEMODM

Financials at a glance

Beauty Skin's latest results and balance sheet. The bars track the last three periods.

Who held it · filings

Filed record

A historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.

US 13F는 분기 공시이며 최대 45일 뒤 제출될 수 있습니다.

5%+ major-holding disclosures

  • 김종수43.25%2025-10-16 · 증감 -3.74%p
  • 글로벌강소기업키움엠앤에이전략창업벤처전문사모투자12.81%2026-01-15 · 증감 -1.01%p
  • 하우자산운용6.45%2024-11-13 · 증감 +6.45%p

Recent filings

Beauty Skin's latest filings on Korea's DART. Open a headline for a reference summary and the original.

Source: DART (Korea electronic disclosure)

Like these rules? Run them automatically.

Quantus turns rules like these into backtests and automated trading — same team, free to start.

Quantus Signal · live data · not investment advice · Privacy Policy